COR (95% CI) | AOR (95% CI) | ||||
---|---|---|---|---|---|
Cured Vs unsuccessful treatment outcome | B(SE) | B(SE) | |||
Age category, in years | −0.02 (0.02) | 0.97 (0.94–0.0.99)* | − 0.04 (0.05) | 0.91 (0.71–2.33) | |
HIV status | Positive | 1.00 | 1.00 | ||
Negative | 2.2 (0.35) | 8.78 (4.41–17.51)** | 2.34 (1.8) | 6.1 (2.1–13.9)* | |
Unknown | 1.8 (1.1) | 6.00 (0.72–13.1) | 0.64 (1.68) | 1.9 (0.07–51.4) | |
Type of TB | Extra PTB | 1.00 | 1.00 | ||
Smear positive PTB | 2.8 (0.46) | 17.8 (7.2–43.8)** | 4.66 (1.2) | 10.5 (5.36–16.31)** | |
Smear negative PTB | −1.4 (0.65) | 0.25 (0.071–0.89)* | − 0.27 (1.1) | 0.77 (0.09–6.58) | |
TB treatment category | New | 1.00 | 1.00 | ||
Retreatment | −1.6 (0.27) | 0.52 (0.34–0.86)* | − 1.1 (0.22) | 0.31 (0.05–0.59) | |
Transfer in | 0.85 (0.69) | 2.33 (0.60–9.02) | 0.54 (0.39) | 2.01 (0.87–3.65) | |
Treatment completed Vs unsuccessful treatment outcome | |||||
Age category in years | −0.03 (0.02) | 0.97 (0.93–0.95)* | − 0.016 (0.81) | 0.99 (0.81–2.99) | |
HIV status | Positive | 1.00 | 1.00 | ||
Negative | 3.1 (0.34) | 21.4 (10.9–39.8)** | 2.07 (1.13) | 4.4 (1.26–15.58)* | |
Unknown | 0.65 (0.0.37) | 1.9 (0.92–3.91) | 0.18 (1.1) | 2.84 (0.096–7.3) | |
Type of TB | Extra PTB | 1.00 | 1.00 | ||
Smear positive PTB | 2.2 (0.31) | 9.1 (5.00–16.5)** | 4.26 (1.28) | 3.8 (1.25–7.4)** | |
Smear negative PTB | 3.46 (0.51) | 2.88 (1.17–7.39)** | 0.91 (0.62) | 1.73 (0.12–4.34) | |
TB treatment category | New | 1.00 | 1.00 | ||
Re-treatment | −1.3 (0.67) | 0.273 (0.024–0.81)* | − 1.9 (0.86) | 0.15 (0.03–0.99) | |
Transfer in | 0.11 (1.04) | 1.42 (0.62–7.2) | 3.2 (1.65) | 2.11 (0.65–3.88) |